ASJC Scopus subject areas
Access to Document
Other files and links
Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA. / Rich, Nicole E.; Noureddin, Mazen; Kanwal, Fasiha; Singal, Amit G.In: The Lancet Gastroenterology and Hepatology, Vol. 6, No. 6, 06.2021, p. 422-424.
Research output: Contribution to journal › Comment/debate › peer-review
TY - JOUR
T1 - Racial and ethnic disparities in non-alcoholic fatty liver disease in the USA
AU - Rich, Nicole E.
AU - Noureddin, Mazen
AU - Kanwal, Fasiha
AU - Singal, Amit G.
N1 - Funding Information: MN has been on the advisory board for 89BIO, Gilead, Intercept, Pfizer, Novartis, Novo Nordisk, Allergan, Blade, EchoSens, Fractyl, Terns, OWL, Siemens, Roche Diagnostic, and Abbott; has received research support from Allergan, Bristol Myers Squibb, Gilead, Galmed, Galectin, Genfit, Conatus, Enanta, Pfizer, Madrigal, Novartis, Shire, Viking’ and Zydus; and is a minor shareholder or has stocks in Anaetos, Rivus Pharma, and Viking. FK reports grants from Merck and Gilead. AGS has been on advisory boards and served as a consultant for Wako Diagnostics, Roche, Exact Sciences, Glycotest, Bayer, Eisai, Exelixis, Bristol Myers Squibb, AstraZeneca, Genentech, and TARGET-RWE. NER declared no competing interests.
PY - 2021/6
Y1 - 2021/6
UR - http://www.scopus.com/inward/record.url?scp=85106266602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106266602&partnerID=8YFLogxK
U2 - 10.1016/S2468-1253(21)00100-X
DO - 10.1016/S2468-1253(21)00100-X
M3 - Comment/debate
C2 - 34015351
AN - SCOPUS:85106266602
VL - 6
SP - 422
EP - 424
JO - The Lancet Gastroenterology and Hepatology
JF - The Lancet Gastroenterology and Hepatology
SN - 2468-1253
IS - 6